Evaluating Hyperbolic Dispersion Materials for Cancer Detection.

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Current biosensors struggle with specificity for low molecular analytes in complex biological fluids.
• Non-specific binding remains a significant challenge in clinical diagnostics.
• Hyperbolic metamaterials (HMMs) present a promising alternative for label-free detection.

Purpose of the Study:

• To review design strategies for hyperbolic metamaterial (HMM)-based biosensors.
• To compare HMM techniques with conventional plasmonic methods for miniaturized devices.
• To explore the development of HMM devices for active cancer bioassay platforms.

Main Methods:

• Detailed discussion of HMM design strategies.
• Comparison of HMMs with conventional plasmonic techniques.
• Focus on low optical loss reconfigurable HMM devices.

Main Results:

• HMMs offer label-free detection with high angular sensitivity, down to 10⁵ M.
• HMMs can circumvent sensitivity issues in current biosensor technology.
• Potential for creating susceptible, miniaturized point-of-care diagnostic devices.

Conclusions:

• HMMs show significant potential for enhancing biosensor specificity and sensitivity.
• Reconfigurable HMM devices are crucial for active cancer biomarker detection platforms.
• Future applications of HMM-based biosensors in cancer diagnostics are promising.